Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China Y. Hu, B. Mathema, Q. Zhao, L. Chen, W. Lu, W. Wang, B. Kreiswirth, B. Xu Clinical Microbiology and Infection Volume 21, Issue 12, Pages 1093.e9-1093.e18 (December 2015) DOI: 10.1016/j.cmi.2015.08.023 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 1 Inclusion of the subjects. Clinical Microbiology and Infection 2015 21, 1093.e9-1093.e18DOI: (10.1016/j.cmi.2015.08.023) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 2 The drug-resistance profile and genetic mutation of the clustered Mycobacterium tuberculosis strain. Clinical Microbiology and Infection 2015 21, 1093.e9-1093.e18DOI: (10.1016/j.cmi.2015.08.023) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 3 The network analysis of the clusters containg the drug-resistant Mycobacterium tuberculosis isolates Each symbol refers to individual clustered patients and each number refers to the cluster number. Abbreviations: DS, drug sensitive; MDR-TB, multidrug-resistant tuberculosis; XDR, extensively drug resistant. Clinical Microbiology and Infection 2015 21, 1093.e9-1093.e18DOI: (10.1016/j.cmi.2015.08.023) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions